Placental biomarkers to predict adverse obstetric and perinatal outcomes

This study aims to evaluate strategies for detecting mothers and babies at an increased-risk of late-pregnancy stillbirth and other adverse pregnancy outcomes. Specific aims include:

Improving understanding and prediction of decreased fetal movements
Assessing the role of routine third-trimester ultrasound scanning in reducing adverse outcomes
Examining the role of PlGF (placental growth factor) in identifying women at-risk
Assessing barriers to morphology scanning